Literature DB >> 31510903

Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging.

Eugene L Scharf1, Jonathan Graff-Radford1, Scott A Przybelski2, Timothy G Lesnick2, Michelle M Mielke1,3, David S Knopman1, Gregory M Preboske4, Christopher G Schwarz4, Matthew L Senjem4, Jeffrey L Gunter4, Mary Machulda5, Kejal Kantarci4, Ronald C Petersen1,3, Clifford R Jack4, Prashanthi Vemuri4.   

Abstract

Background and Purpose- White matter hyperintensity (WMH) burden is associated with stroke and cognitive decline. Risk factors associated with the longitudinal progression of WMH in the general population have not been systematically investigated. To investigate the primary midlife and current cardiometabolic risk factors associated with changes in WMH over time in a population cohort. Methods- This cohort study included participants enrolled in the Mayo Clinic Study of Aging, a longitudinal population-based study in Olmsted County, Minnesota with at least 2 consecutive WMH assessments on fluid-attenuated inversion recovery-magnetic resonance images (n=554, ≥60 years with midlife assessments) with relevant baseline laboratory measures of interest. Linear mixed model regression was used to determine the important components of cardiometabolic risk profile at baseline that were associated with future progression of WMH. These analyses were controlled for age and sex. Sensitivity analyses were conducted using stratification by sex. The main outcome measure was percent change in WMH normalized to total intracranial volume. Three sets of models were constructed to evaluate individual (1) midlife risk factors, (2) current risk factors including the presence of metabolic syndrome and its constituents, and (3) baseline measurements of continuous laboratory measures of cardiometabolic risk. Results- Age was the strongest predictor of progression in WMH (P<0.001). Baseline hypertension (P<0.001), midlife hypertension (P=0.003), and baseline fasting glucose in males (P=0.01) were predictive of WMH change. The presence of metabolic syndrome was not associated with progressive WMH. In sensitivity analyses, associations between hypertension and WMH progression were stronger in females. Baseline serum glucose was associated with increase in WMH but was not significant in females in the stratified analysis. Other continuous laboratory measures of vascular risk were not associated with progressive WMH. Conclusions- Midlife and current hypertension in all participants and fasting glucose in males were associated with quantitative changes in white matter. Prospective clinical studies should determine optimal blood pressure to reduce stroke and cognitive impairment during aging.

Entities:  

Keywords:  blood pressure; hypertension; magnetic resonance imaging; metabolic syndrome; white matter

Mesh:

Substances:

Year:  2019        PMID: 31510903      PMCID: PMC6817406          DOI: 10.1161/STROKEAHA.119.025822

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  32 in total

1.  Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury: A Systematic Review and Meta-analysis.

Authors:  Stéphanie Debette; Sabrina Schilling; Marie-Gabrielle Duperron; Susanna C Larsson; Hugh S Markus
Journal:  JAMA Neurol       Date:  2019-01-01       Impact factor: 18.302

2.  Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy.

Authors:  Carole Dufouil; John Chalmers; Oguzhan Coskun; Véronique Besançon; Marie-Germaine Bousser; Pierre Guillon; Stephen MacMahon; Bernard Mazoyer; Bruce Neal; Mark Woodward; Nathalie Tzourio-Mazoyer; Christophe Tzourio
Journal:  Circulation       Date:  2005-09-06       Impact factor: 29.690

3.  Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging.

Authors:  R C Petersen; R O Roberts; D S Knopman; Y E Geda; R H Cha; V S Pankratz; B F Boeve; E G Tangalos; R J Ivnik; W A Rocca
Journal:  Neurology       Date:  2010-09-07       Impact factor: 9.910

4.  Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study.

Authors:  D Liao; L Cooper; J Cai; J F Toole; N R Bryan; R G Hutchinson; H A Tyroler
Journal:  Stroke       Date:  1996-12       Impact factor: 7.914

5.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

Authors:  W T Longstreth; T A Manolio; A Arnold; G L Burke; N Bryan; C A Jungreis; P L Enright; D O'Leary; L Fried
Journal:  Stroke       Date:  1996-08       Impact factor: 7.914

6.  Hypertension, white matter hyperintensities, and concurrent impairments in mobility, cognition, and mood: the Cardiovascular Health Study.

Authors:  Ihab Hajjar; Lien Quach; Frances Yang; Paulo H M Chaves; Anne B Newman; Kenneth Mukamal; Will Longstreth; Marco Inzitari; Lewis A Lipsitz
Journal:  Circulation       Date:  2011-02-14       Impact factor: 29.690

7.  The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study.

Authors:  Ewoud J van Dijk; Monique M B Breteler; Reinhold Schmidt; Klaus Berger; Lars-Göran Nilsson; Matthijs Oudkerk; Andrzej Pajak; Susana Sans; Maria de Ridder; Carole Dufouil; Rebecca Fuhrer; Simona Giampaoli; Lenore J Launer; Albert Hofman
Journal:  Hypertension       Date:  2004-10-04       Impact factor: 10.190

8.  Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.

Authors:  Tom Jeerakathil; Philip A Wolf; Alexa Beiser; Joseph Massaro; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli
Journal:  Stroke       Date:  2004-06-24       Impact factor: 7.914

9.  The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.

Authors:  Rosebud O Roberts; Yonas E Geda; David S Knopman; Ruth H Cha; V Shane Pankratz; Bradley F Boeve; Robert J Ivnik; Eric G Tangalos; Ronald C Petersen; Walter A Rocca
Journal:  Neuroepidemiology       Date:  2008-02-07       Impact factor: 3.282

Review 10.  History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population.

Authors:  Walter A Rocca; Barbara P Yawn; Jennifer L St Sauver; Brandon R Grossardt; L Joseph Melton
Journal:  Mayo Clin Proc       Date:  2012-11-28       Impact factor: 7.616

View more
  8 in total

1.  The relation between antihypertensive treatment and progression of cerebral small vessel disease: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Chen Su; Hao Wu; Xiaoyu Yang; Bing Zhao; Renliang Zhao
Journal:  Medicine (Baltimore)       Date:  2021-07-30       Impact factor: 1.817

2.  Chronic Kidney Disease Associated with Worsening White Matter Disease and Ventricular Enlargement.

Authors:  Prashanthi Vemuri; Cynthia Davey; Kirsten L Johansen; Samantha M Zuk; Robert I Reid; Kaely B Thostenson; Ashritha L Reddy; Clifford R Jack; David S Knopman; Anne M Murray
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.160

Review 3.  The Association Between Hypertension and Cognitive Impairment, and the Role of Antihypertensive Medications: A Literature Review.

Authors:  Nupur Mishra; Devyani Mohan; Sehrish Fuad; Deepak M Basavanagowda; Zaid A Alrashid; Arveen Kaur; Bindu Rathod; Sadia Nosher; Stacey E Heindl
Journal:  Cureus       Date:  2020-12-11

4.  Impact of Peripheral Microvascular Endothelial Dysfunction on White Matter Hyperintensity.

Authors:  Takumi Toya; Jaskanwal D Sara; Eugene L Scharf; Ali Ahmad; Valentina Nardi; Ilke Ozcan; Lilach O Lerman; Amir Lerman
Journal:  J Am Heart Assoc       Date:  2021-10-08       Impact factor: 5.501

5.  Leukoaraiosis and Gray Matter Volume Alteration in Older Adults: The PROOF Study.

Authors:  Sébastien Celle; Claire Boutet; Cédric Annweiler; Romain Ceresetti; Vincent Pichot; Jean-Claude Barthélémy; Frédéric Roche
Journal:  Front Neurosci       Date:  2022-01-13       Impact factor: 4.677

6.  Longitudinal white matter hyperintensity changes and cognitive decline in patients with minor stroke.

Authors:  Jingwen Jiang; Kanmin Yao; Xiaojun Huang; Yu Zhang; Fanxia Shen; Suiqing Weng
Journal:  Aging Clin Exp Res       Date:  2022-01-27       Impact factor: 4.481

Review 7.  Common Brain Structural Alterations Associated with Cardiovascular Disease Risk Factors and Alzheimer's Dementia: Future Directions and Implications.

Authors:  Melissa Lamar; Elizabeth A Boots; Konstantinos Arfanakis; Lisa L Barnes; Julie A Schneider
Journal:  Neuropsychol Rev       Date:  2020-10-03       Impact factor: 7.444

8.  Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study.

Authors:  Karolina Agnieszka Wartolowska; Alastair John Stewart Webb
Journal:  Eur Heart J       Date:  2021-02-14       Impact factor: 35.855

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.